Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. News
  7. Summary
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Everest Medicines : Taiwan to Expedite Review of Everest Medicines' Breast Cancer Drug

07/30/2021 | 06:04am EDT


© MT Newswires 2021
All news about EVEREST MEDICINES LIMITED
09/17EVEREST MEDICINES : Wins License to Kidney Disease Treatment; Shares Rise 4%
MT
09/16EVEREST MEDICINES : Sinovent and SinoMab Announce Licensing Agreement for Global..
PR
09/14EVEREST MEDICINES : China's Everest Medicines Strikes Vaccine Deal With Canada's..
MT
09/13EVEREST MEDICINES : to bring Canadian biotech's potential COVID shots to China, ..
RE
09/13EVEREST MEDICINES : Enters into Comprehensive Agreements with Providence Therape..
PR
09/13Providence Therapeutics Holdings Inc. Enters into Comprehensive Agreements wi..
CI
08/30EVEREST MEDICINES : Announces Up to HK$100 million Share Repurchase Program
PR
08/30EVEREST MEDICINES : Announces Half-Year 2021 Interim Results
PR
08/30Everest Medicines Limited Reports Unaudited Consolidated Earnings Results for..
CI
08/27EVEREST MEDICINES : Doses First Patient in China Clinical Trial of Cancer Therap..
MT
More news
Analyst Recommendations on EVEREST MEDICINES LIMITED
More recommendations
Financials
Sales 2021 1,92 M 0,30 M 0,30 M
Net income 2021 -1 033 M -160 M -160 M
Net cash 2021 2 974 M 460 M 460 M
P/E ratio 2021 -15,6x
Yield 2021 -
Capitalization 16 180 M 2 503 M 2 503 M
EV / Sales 2021 6 890x
EV / Sales 2022 29,0x
Nbr of Employees 227
Free-Float 98,1%
Chart EVEREST MEDICINES LIMITED
Duration : Period :
Everest Medicines Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVEREST MEDICINES LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 54,34 CNY
Average target price 85,68 CNY
Spread / Average Target 57,7%
EPS Revisions
Managers and Directors
Kerry Levan Blanchard Chief Executive Officer & Executive Director
Ian Ying Woo President, CFO & Executive Director
Wei Fu Chairman
Jennifer Yang Chief Scientific Officer
Xiaofan Zhang Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EVEREST MEDICINES LIMITED-3.40%2 503
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604